News
WILCO Startup Cluster

WILCO startup cluster

HEPHAISTOS-Pharma was selected by WILCO startup cluster to obtain capital loans and increase our own funds.

Related Posts

Orphan Drug Designation

The European Medicines Agency (EMA) has granted Orphan Drug Designation to ONCO-Boost (HEPHAISTOS-Pharma) as treatment…

University Paris Saclay

HEPHAISTOS-Pharma was present at the Event organized by the University Paris Saclay for its collaborating…

Back To Top